Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

Blood (2025) 146 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2025-1413

Published: 2025

Journal Articles

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Ao-Ran Zhang, Guanhua Hu, Xianying Yin, Sheng-Ye Lu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiangyu Zhao, Xiaojun Huang, Yi-Fei Cheng, Meng Lv

Blood (2025) 146 (Supplement 1): 4298.

https://doi.org/10.1182/blood-2025-4298

Published: 2025

Journal Articles

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Xiangyu Zhao, Zhengli Xu, Meng Lv, Xingxing Yu, Yiyang Ding, Ting-ting Han, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Lanping Xu, Xiaohui Zhang, Yu Wang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 7774.

https://doi.org/10.1182/blood-2025-7774

Published: 2025

Journal Articles

Ectopic EBV infection in T cells following allogeneic hematopoietic stem cell transplantation: Clinical outcomes and immunological characterization

Zhifan Zhao, Lanping Xu, Xiangyu Zhao, Yu Wang, Xiaohui Zhang, Xiaojun Huang, Xuying Pei

Blood (2025) 146 (Supplement 1): 2449.

https://doi.org/10.1182/blood-2025-2449

Published: 2025

Journal Articles

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Blood (2025) 146 (Supplement 1): 120.

https://doi.org/10.1182/blood-2025-120

Published: 2025

Journal Articles

Novel insights from the largest cohort to date: Elucidating risk factors, clinical outcomes, and prognostic predictors in autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation

Liqian Zhang, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Yuqian Sun, Meng Lv, Xiangyu Zhao, YuHong Chen, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6046.

https://doi.org/10.1182/blood-2025-6046

Published: 2025

Journal Articles

Thrombotic thrombocytopenic purpura after allogeneic hematopoietic cell transplantation: A rare but fatal complication.

Blood (2025) 146 (Supplement 1): 6045.

https://doi.org/10.1182/blood-2025-6045

Published: 2025

Journal Articles

Comparative high-dimensional profiling reveals distinct immune reconstitution dynamics between CD19 and CD7 CAR-T therapies in acute leukemia

Xuying Pei, Zhipeng Zhou, Zhifan Zhao, Meng Lv, Xiangyu Zhao, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 4099.

https://doi.org/10.1182/blood-2025-4099

Published: 2025

Journal Articles

Baricitinib reveals LGALS3BP as a novel pathogenic factor and therapeutic target in immune thrombocytopenia

Kexin Shen, Jingli Han, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Qiu-Sha Huang, Jin Wu, Li-Ping Yang, Yuanyuan Zhang, Ying-jun Chang, Xiangyu Zhao, Yu Wang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 846.

https://doi.org/10.1182/blood-2025-846

Published: 2025

Journal Articles

Next-day manufactured CD19 CAR-T cells exhibit superior persistence compared to conventional CAR-T therapy in R/R B-ALL

Meng Lv, Xu-Ying Pei, Yan-Ping Ding, Zhipeng Zhou, Luhan Deng, Zhuo-Jun Liu, Jing Liu, Leping Zhang, Qian Jiang, Xiaohui Zhang, Xin-An Lu, Xiao-Zheng Zhao, Guang-Hua Liu, Ting He, Xiaojun Huang, Xiangyu Zhao

Blood (2025) 146 (Supplement 1): 2407.

https://doi.org/10.1182/blood-2025-2407

Published: 2025

Journal Articles

CD132 expression promotes AML aggressiveness via the JAK-STAT signaling pathway

Yiyang Ding, Luhan Deng, Xunhong Cao, Zeying Fan, Juan Xie, Qiannan Shang, Yahui Li, Xinyu Dong, Ming Zhao, Meiju Deng, Lijuan Hu, Zhengli Xu, Bo Han, Zhengwei Xie, Xiaojun Huang, Xiangyu Zhao

Blood (2025) 146 (Supplement 1): 3481.

https://doi.org/10.1182/blood-2025-3481

Published: 2025

Journal Articles

Outcome and recovery trajectories for intracerebral hemorrhage in adults with primary immune thrombocytopenia

Peng Zhao, Ming Hou, Yi Liu, Ru Feng, Yujun Dong, Hai-Xia Fu, Qiu-Sha Huang, Jin Wu, Zhuoyu An, Yuanyuan Zhang, Xiangyu Zhao, Ying-jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3033.

https://doi.org/10.1182/blood-2025-3033

Published: 2025

Journal Articles

Impact of HLA-b leader matching status on prognosis and underlying mechanism in patients with hematological malignancies following haploidentical hematopoietic stem cell transplantation

Minghao Lin, Yuanyuan Zhang, Zhengli Xu, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Xiangyu Zhao

Blood (2025) 146 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2025-2496

Published: 2025

Journal Articles

A novel predictive model for posttransplant lymphoproliferative disorder in the letermovir prophylaxis era

Chen-Cong Wang, Xuying Pei, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Yuqian Sun, Meng Lv, Xiangyu Zhao, Yuhong Chen, Yu Wang, Ying-Jun Chang, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4269.

https://doi.org/10.1182/blood-2025-4269

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Peng Zhao, Zhixue Li, Erlie Jiang, Shengjin Fan, Pengcheng He, Jingzhi Wang, Linghui Xia, Qiu-Sha Huang, Jin Wu, Zhuoyu An, Hai-Xia Fu, Yuanyuan Zhang, Xiangyu Zhao, Yu Wang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4263.

https://doi.org/10.1182/blood-2025-4263

Published: 2025

Journal Articles

CARMA-1: The phase I Study of SENL101, a naturally selected nanobody based CD7 CAR-T therapy, in relapsed or refractory T-ALL/lbl

Xiangyu Zhao, Wei Li Zhao, Xiaoxi Zhou, Huilai Zhang, Ting Niu, Hongsheng Zhou, Aibin Liang, Xi Zhang, Meng Lv, Lingshuang Sheng, Na Kuang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 5931.

https://doi.org/10.1182/blood-2025-5931

Published: 2025

Journal Articles

Donor-Derived Unlicensed NK Cells Promote the Hematopoietic Recovery after Allogeneic Hematopoietic Stem Cell Transplantation

Ding Yiyang, Ming Zhao, Xiang Wang, Juan Xie, Qian-Nan Shang, Xun-Hong Cao, Xiaohui Zhang, Xiao-Jun Huang, Xiangyu Zhao

Blood (2024) 144 (Supplement 1): 4773.

https://doi.org/10.1182/blood-2024-210445

Published: 2024

Journal Articles

LILRB4 Synthetic T-Cell Receptor and Antigen Receptor-T (STAR-T) for Refractory/Relapsed Acute Myeloid Leukemia: First-in-Human Phase I Clinical Trial

Xiangyu Zhao, Meng Lv, Yu Wang, Yi-Yang Ding, Zhixiao Zhou, Jiasheng Wang, HongLi Zheng, Xueqiang Zhao, Xin Lin, Xiao Jun Huang

Blood (2024) 144 (Supplement 1): 4831.

https://doi.org/10.1182/blood-2024-207297

Published: 2024

Journal Articles

Coagulation Biomarker Signature As a Novel Differential Diagnostic Tool for CRS/Icans and Infection Post-CAR-T Therapy

Xianying Yin, Ao-Ran Zhang, Yu-Tong Bao, Yu Wang, Lanping Xu, Xiao-Hui Zhang, Xiangyu Zhao, Xiaojun Huang, Meng Lv

Blood (2024) 144 (Supplement 1): 7219.

https://doi.org/10.1182/blood-2024-207496

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Ectopic EBV infection in T cells following allogeneic hematopoietic stem cell transplantation: Clinical outcomes and immunological characterization

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Novel insights from the largest cohort to date: Elucidating risk factors, clinical outcomes, and prognostic predictors in autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation

Thrombotic thrombocytopenic purpura after allogeneic hematopoietic cell transplantation: A rare but fatal complication.

Comparative high-dimensional profiling reveals distinct immune reconstitution dynamics between CD19 and CD7 CAR-T therapies in acute leukemia

Baricitinib reveals LGALS3BP as a novel pathogenic factor and therapeutic target in immune thrombocytopenia

Next-day manufactured CD19 CAR-T cells exhibit superior persistence compared to conventional CAR-T therapy in R/R B-ALL

CD132 expression promotes AML aggressiveness via the JAK-STAT signaling pathway

Outcome and recovery trajectories for intracerebral hemorrhage in adults with primary immune thrombocytopenia

Impact of HLA-b leader matching status on prognosis and underlying mechanism in patients with hematological malignancies following haploidentical hematopoietic stem cell transplantation

A novel predictive model for posttransplant lymphoproliferative disorder in the letermovir prophylaxis era

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

CARMA-1: The phase I Study of SENL101, a naturally selected nanobody based CD7 CAR-T therapy, in relapsed or refractory T-ALL/lbl

Donor-Derived Unlicensed NK Cells Promote the Hematopoietic Recovery after Allogeneic Hematopoietic Stem Cell Transplantation

LILRB4 Synthetic T-Cell Receptor and Antigen Receptor-T (STAR-T) for Refractory/Relapsed Acute Myeloid Leukemia: First-in-Human Phase I Clinical Trial

Coagulation Biomarker Signature As a Novel Differential Diagnostic Tool for CRS/Icans and Infection Post-CAR-T Therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only